Normal view MARC view ISBD view

Holland-Frei cancer medicine / editors, Robert C. Bast, Jr. ... [et al.].

Contributor(s): Bast, Robert C., Jr. (Robert Clinton), 1943- [editor.].
Material type: materialTypeLabelBookCall no.: QZ200 .C36 2016Publication: Hoboken, New Jersey : John Wiley & Sons, Inc., 2016Edition: 9th ed.Description: xxix, 1971 p. : col. ill.ISBN: 9781118934692; 1118934695.Other title: Cancer medicine.Subject(s): Neoplasms
Contents:
1. Cardinal manifestations of cancer -- 2. Biological hallmarks of cancer -- Part 2: TUMOR BIOLOGY -- 3. Molecular biology, genomics, proteomics, and mouse models of human cancer -- 4. Oncogenes -- 5. Tumor suppressor genes -- 6. Epigenetic contributions to human cancer -- 7. Cancer genomics and evolution -- 8. Chromosomal aberrations in cancer -- 9. MicroRNA expression in cancer -- 10. Aberrant signaling pathways in cancer -- 11. Differentiation therapy -- 12. Cancer stem cells -- 13. Cancer and cell death -- 14. Cancer cell immortality: targeting telomerase -- 15. Cancer metabolism --
16. Modeling therapy of late or early-stage metastatic disease in mice -- 17. Tumor angiogenesis -- 18. Cancer bioinformatics -- 19. Systems biology and genomics -- 20. Statistical innovations in cancer research -- 21. Biomarker-based clinical trial design in the era of genomic medicine -- 22. Clinical informatics -- Part 4: CARCINOGENESIS -- 23. Chemical carcinogenesis -- 24. Endocrine and genetic bases of hormone-related cancers -- 25. Ionizing radiation -- 26. Ultraviolet radiation carcinogenesis -- 27. Inflammation and cancer -- 28. RNA tumor viruses -- 29. Herpesviruses -- 30. Papillomaviruses and cervical neoplasia --
31. Hepatitis viruses and hepatoma -- 32. Parasites -- 33. The burden of cancer worldwide: current and future perspectives -- 34. Cancer epidemiology -- 35. Behavioral approaches to cancer prevention -- 36. Diet and nutrition in the etiology and prevention of cancer -- 37. Chemoprevention of cancer -- 38. Cancer screening and early detection -- 39. Nexgen pathology: predicting clinical course and targeting disease causation -- 40. Molecular diagnostics in cancer -- 41. Principles of imaging -- 42. Interventional radiology for the cancer patient -- 43. Principles of surgical oncology -- 44. Principles of radiation oncology -- 45. Principles of medical oncology -- 46. Palliative care and pain management -- 47. Principles of psycho-oncology -- 48. Principles of cancer rehabilitation medicine -- 49. Integrative oncology in cancer care -- 50. Health services research --
51. Personalized medicine in oncology drug development -- 52. Preclinical and early clinical development of chemotherapeutic drugs, mechanism-based agents and biologics -- 53. Tumor growth kinetics -- 54. Principles of dose, schedule, and combination therapy -- 55. Pharmacology -- 56. Folate antagonists -- 57. Pyrimidine and purine antimetabolites -- 58. Alkylating agents and platinum antitumor compounds -- 59. DNA topoisomerase targeting drugs -- 60. Agents targeting microtubules and mitotic processes -- 61. Endocrine therapy for hormone receptor-positive breast cancer -- 62. Drug resistance and its clinical circumvention -- 63. Cytokines, interferons, and hematopoietic growth factors -- 64. Monoclonal serotherapy -- 65. Vaccines and immunostimulants --
66. Cell-based cancer immunotherapy -- 67. Cancer immunotherapy -- 68. Cancer gene therapy -- 69. Cancer nanotechnology -- 70. Hematopoietic cell transplantation -- 71. Principles of pediatric oncology -- 72. Cancer and pregnancy -- 73. Cancer and aging -- 74. Disparities in cancer care -- 75. Neoplasms in acquired immunodeficiency syndrome -- 76. Cancer survivorship: new challenge in cancer medicine -- Part 11: DISEASE SITES -- 77. Primary and metastatic neoplasms of the brain in adults --78. Neoplasms of the eye -- 79. Neoplasms of the endocrine glands: pituitary neoplasms -- 80. Neoplasms of the thyroid -- 81. Neoplasms of the adrenal cortex -- 82. Tumors of the diffuse neuroendocrine and gastroenteropancreatic system -- 83. Neoplasms of the head and neck -- 84. Cancer of the lung -- 85. Malignant pleural mesothelioma -- 86. Thymomas and thymic tumors -- 87. Tumors of the heart and great vessels -- 88. Primary germ cell tumors of the thorax -- 89. Neoplasms of the esophagus -- 90. Carcinoma of the stomach -- 91. Primary neoplasms of the liver -- 92. Gallbladder and bile duct cancer -- 93. Neoplasms of the exocrine pancreas -- 94. Neoplasms of the small intestine, vermiform appendix, and peritoneum, and carcinoma of the colon and rectum -- 95. Neoplasms of the anus --
96. Renal cell carcinoma -- 97. Urothelial cancer -- 98. Neoplasms of the prostate -- 99. Tumors of the penis and the urethra -- 100. Testis cancer -- 101. Neoplasms of the vulva and vagina -- 102. Neoplasms of the cervix -- 103. Endometrial cancer -- 104. Epithelial ovarian, fallopian tube, and peritoneal cancer -- 105. Nonepithelial ovarian malignancies -- 106. Molar pregnancy and gestational trophoblastic neoplasia -- 107. Gynecologic sarcomas -- 108. Neoplasms of the breast -- 109. Malignant melanoma -- 110. Other skin cancers -- 111. Bone tumors -- 112. Soft tissue sarcomas -- 113. The myelodysplastic syndrome -- 114. Acute myeloid leukemia in adults: mast cell leukemia and other mast cell neoplasms -- 115. Chronic myeloid leukemia -- 116. Acute lymphoblastic leukemia -- 117. Chronic lymphocytic leukemia -- 118. Hodgkin lymphoma -- 119. Non-Hodgkin's lymphoma -- 120. Mycosis fungoides and Sézary syndrome -- 121. Plasma cell tumors -- 122. Myeloproliferative neoplasms: essential thrombocythemia, primary myelofibrosis, and polycythemia vera -- 123. Neoplasms of unknown primary site -- 124. Anorexia and cachexia -- 125. Antiemetic therapy -- 126. Neurologic complications of cancer -- 127. Dermatologic complications of cancer chemotherapy -- 128. Skeletal complications -- 129. Hematologic complications and blood bank support -- 130. Coagulopathic complications of cancer patients --
131. Urologic complications -- 132. Cardiac complications -- 133. Respiratory complications -- 134. Gastrointestinal and hepatic complications in cancer patients -- 135. Oral complications of cancer and their treatment -- 136. Gonadal complications -- 137. Sexual dysfunction -- 138. Endocrine complications and paraneoplastic syndromes -- 139. Infections in patients with cancer -- 140. Oncologic emergencies -- 141. A vision for twenty-first century healthcare.
List(s) this item appears in: TUMED-New Book 2018-October (Foreign)
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)

Includes bibliographical references and index.

1. Cardinal manifestations of cancer -- 2. Biological hallmarks of cancer -- Part 2: TUMOR BIOLOGY -- 3. Molecular biology, genomics, proteomics, and mouse models of human cancer -- 4. Oncogenes -- 5. Tumor suppressor genes -- 6. Epigenetic contributions to human cancer -- 7. Cancer genomics and evolution -- 8. Chromosomal aberrations in cancer -- 9. MicroRNA expression in cancer -- 10. Aberrant signaling pathways in cancer -- 11. Differentiation therapy -- 12. Cancer stem cells -- 13. Cancer and cell death -- 14. Cancer cell immortality: targeting telomerase -- 15. Cancer metabolism --

16. Modeling therapy of late or early-stage metastatic disease in mice -- 17. Tumor angiogenesis -- 18. Cancer bioinformatics -- 19. Systems biology and genomics -- 20. Statistical innovations in cancer research -- 21. Biomarker-based clinical trial design in the era of genomic medicine -- 22. Clinical informatics -- Part 4: CARCINOGENESIS -- 23. Chemical carcinogenesis -- 24. Endocrine and genetic bases of hormone-related cancers -- 25. Ionizing radiation -- 26. Ultraviolet radiation carcinogenesis -- 27. Inflammation and cancer -- 28. RNA tumor viruses -- 29. Herpesviruses -- 30. Papillomaviruses and cervical neoplasia --

31. Hepatitis viruses and hepatoma -- 32. Parasites -- 33. The burden of cancer worldwide: current and future perspectives -- 34. Cancer epidemiology -- 35. Behavioral approaches to cancer prevention -- 36. Diet and nutrition in the etiology and prevention of cancer -- 37. Chemoprevention of cancer -- 38. Cancer screening and early detection -- 39. Nexgen pathology: predicting clinical course and targeting disease causation -- 40. Molecular diagnostics in cancer -- 41. Principles of imaging -- 42. Interventional radiology for the cancer patient -- 43. Principles of surgical oncology -- 44. Principles of radiation oncology -- 45. Principles of medical oncology -- 46. Palliative care and pain management -- 47. Principles of psycho-oncology -- 48. Principles of cancer rehabilitation medicine -- 49. Integrative oncology in cancer care -- 50. Health services research --

51. Personalized medicine in oncology drug development -- 52. Preclinical and early clinical development of chemotherapeutic drugs, mechanism-based agents and biologics -- 53. Tumor growth kinetics -- 54. Principles of dose, schedule, and combination therapy -- 55. Pharmacology -- 56. Folate antagonists -- 57. Pyrimidine and purine antimetabolites -- 58. Alkylating agents and platinum antitumor compounds -- 59. DNA topoisomerase targeting drugs -- 60. Agents targeting microtubules and mitotic processes -- 61. Endocrine therapy for hormone receptor-positive breast cancer -- 62. Drug resistance and its clinical circumvention -- 63. Cytokines, interferons, and hematopoietic growth factors -- 64. Monoclonal serotherapy -- 65. Vaccines and immunostimulants --

66. Cell-based cancer immunotherapy -- 67. Cancer immunotherapy -- 68. Cancer gene therapy -- 69. Cancer nanotechnology -- 70. Hematopoietic cell transplantation -- 71. Principles of pediatric oncology -- 72. Cancer and pregnancy -- 73. Cancer and aging -- 74. Disparities in cancer care -- 75. Neoplasms in acquired immunodeficiency syndrome -- 76. Cancer survivorship: new challenge in cancer medicine -- Part 11: DISEASE SITES -- 77. Primary and metastatic neoplasms of the brain in adults --78. Neoplasms of the eye -- 79. Neoplasms of the endocrine glands: pituitary neoplasms -- 80. Neoplasms of the thyroid -- 81. Neoplasms of the adrenal cortex -- 82. Tumors of the diffuse neuroendocrine and gastroenteropancreatic system -- 83. Neoplasms of the head and neck -- 84. Cancer of the lung -- 85. Malignant pleural mesothelioma -- 86. Thymomas and thymic tumors -- 87. Tumors of the heart and great vessels -- 88. Primary germ cell tumors of the thorax -- 89. Neoplasms of the esophagus -- 90. Carcinoma of the stomach -- 91. Primary neoplasms of the liver -- 92. Gallbladder and bile duct cancer -- 93. Neoplasms of the exocrine pancreas -- 94. Neoplasms of the small intestine, vermiform appendix, and peritoneum, and carcinoma of the colon and rectum -- 95. Neoplasms of the anus --

96. Renal cell carcinoma -- 97. Urothelial cancer -- 98. Neoplasms of the prostate -- 99. Tumors of the penis and the urethra -- 100. Testis cancer -- 101. Neoplasms of the vulva and vagina -- 102. Neoplasms of the cervix -- 103. Endometrial cancer -- 104. Epithelial ovarian, fallopian tube, and peritoneal cancer -- 105. Nonepithelial ovarian malignancies -- 106. Molar pregnancy and gestational trophoblastic neoplasia -- 107. Gynecologic sarcomas -- 108. Neoplasms of the breast -- 109. Malignant melanoma -- 110. Other skin cancers -- 111. Bone tumors -- 112. Soft tissue sarcomas -- 113. The myelodysplastic syndrome -- 114. Acute myeloid leukemia in adults: mast cell leukemia and other mast cell neoplasms -- 115. Chronic myeloid leukemia -- 116. Acute lymphoblastic leukemia -- 117. Chronic lymphocytic leukemia -- 118. Hodgkin lymphoma -- 119. Non-Hodgkin's lymphoma -- 120. Mycosis fungoides and Sézary syndrome -- 121. Plasma cell tumors -- 122. Myeloproliferative neoplasms: essential thrombocythemia, primary myelofibrosis, and polycythemia vera -- 123. Neoplasms of unknown primary site -- 124. Anorexia and cachexia -- 125. Antiemetic therapy -- 126. Neurologic complications of cancer -- 127. Dermatologic complications of cancer chemotherapy -- 128. Skeletal complications -- 129. Hematologic complications and blood bank support -- 130. Coagulopathic complications of cancer patients --

131. Urologic complications -- 132. Cardiac complications -- 133. Respiratory complications -- 134. Gastrointestinal and hepatic complications in cancer patients -- 135. Oral complications of cancer and their treatment -- 136. Gonadal complications -- 137. Sexual dysfunction -- 138. Endocrine complications and paraneoplastic syndromes -- 139. Infections in patients with cancer -- 140. Oncologic emergencies -- 141. A vision for twenty-first century healthcare.

There are no comments for this item.

Click on an image to view it in the image viewer

Open Library:

Thammasat University Library
2 Prachan Road, Phranakorn, Bangkok 10200
Tel: 662 613-3544 (Pridi Banomyong Library, Circulation Desk)
Tel: 662 564-4444 ext. 1305 (Puey Ungphakorn Library (Rangsit Campus), Circulation Desk)